SCHEMBL11288

SCHEMBL11288

O=C1CC(O)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15494454 1.00
Hydrochloric Acid SCHEMBL3986242 0.97
Phosphine SCHEMBL22345181 0.97
Ammonia Solution, Strong SCHEMBL25176856 0.97
SCHEMBL320576 0.97
Ethane SCHEMBL28857929 0.95 MAP3K14 (0.46)
Hydrochloric Acid SCHEMBL28901164 0.95 MAP3K14 (0.46)
Bicarbonate SCHEMBL14918 0.93 MAP3K14 (0.44)
Oxalic Acid SCHEMBL9728854 0.91 MAP3K14 (0.43)
Formic Acid SCHEMBL22361320 0.91 MAP3K14 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 20259 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746858-A2 COATED NANOPARTICLES AND THEIR USE FOR DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS Politecnico Di Torino (IT) 2026-05-27 EP claimed
CN-122080613-A High-strength high-temperature-resistant corrosion-resistant perfluoroether sealing ring 2026-05-26 CN claimed
CN-122036837-A Modification method of antibody 北京拓维生合科技有限公司 2026-05-15 CN claimed
CN-122011095-A Acetyl hexapeptide, preparation method and application thereof 中科纳瑞(苏州)科技有限公司 2026-05-12 CN claimed
US-12617971-B2 Anti-viral coating composition, and method for fixing anti-viral fusion protein to surfaces AMOLIFESCIENCE CO., LTD. (KR) 2026-05-05 US claimed
US-12611460-B2 Eyedrop compositions THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2026-04-28 US claimed
EP-4724455-A1 MULTIVALENT BINDING UNIT MODIFIED DIDEOXYNUCLEOTIDE TRIPHOSPHATES AND METHODS OF MAKING AND USING THE SAME ILLUMINA, INC. (US) 2026-04-15 EP claimed
EP-4446424-B1 METHOD OF MAKING A CARBON-ENZYME LAYER FOR A WORKING ELECTRODE OF A CONTINUOUS BIOLOGICAL MONITOR ALLEZ HEALTH INC (US) 2026-01-28 EP claimed
EP-4680292-A2 ADHESIVE NONFIBROTIC INTERFACES AND METHODS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2026-01-21 EP claimed
US-20260014294-A1 NERVE REGENERATION-INDUCING MATERIAL TAZUKE KOFUKAI (JP) 2026-01-15 US claimed
EP-0396116-A2 Covalent attachment of specific binding members to a solid phase ABBOTT LABORATORIES (US) 1990-11-07 EP claimed
EP-0371495-A2 Sialic acid derivative with active ester groups MECT CORPORATION (JP) 1990-06-06 EP claimed
EP-0362031-A1 Compounds active against malaria of the tissues, and process for their preparation LA REGION WALLONNE (BE) 1990-04-04 EP claimed
EP-0107053-B1 HUMAN LEUKEMIA VIRUS-RELATED PEPTIDES, ANTIBODIES OF THE PEPTIDES AND A PROCESS FOR PRODUCTION OF THE ANTIBODIES JAPANESE FOUNDATION FOR CANCER RESEARCH (JP) 1989-09-13 EP claimed
EP-0286491-A1 Antimalarial aminoquinoline derivatives, method for their preparation and pharmaceutical composition containing them LA REGION WALLONNE (BE) 1988-10-12 EP claimed
EP-0247860-A2 Tumor necrosis factor formulation and its preparation CETUS ONCOLOGY CORPORATION (US) 1987-12-02 EP claimed
EP-0018793-B1 PEPTIDES AND PROCESS FOR THEIR PREPARATION ORTHO PHARMACEUTICAL CORPORATION (US) 1983-11-09 EP claimed
EP-0019115-B1 PANCREOZYMIN-CHOLEZYSTOKININ ACTIVE PEPTIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1983-01-12 EP claimed
US-4250086-A Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2 ORTHO PHARMACEUTICAL CORPORATION (US) 1981-02-10 US claimed
EP-0018793-A2 Peptides and process for their preparation ORTHO PHARMACEUTICAL CORPORATION (US) 1980-11-12 EP claimed